Definition of Dostarlimab. Meaning of Dostarlimab. Synonyms of Dostarlimab

Here you will find one or more explanations in English for the word Dostarlimab. Also in the bottom left of the page several parts of wikipedia pages related to the word Dostarlimab and, of course, Dostarlimab synonyms and on the right images related to the word Dostarlimab.

Definition of Dostarlimab

No result for Dostarlimab. Showing similar results...

Meaning of Dostarlimab from wikipedia

- Dostarlimab, sold under the brand name Jemperli, is a monoclonal antibody used as an anti-cancer medication for the treatment of endometrial cancer. Dostarlimab...
- CSCC who are not candidates for curative surgery or curative radiation. Dostarlimab (Jemperli) – was developed by GlaxoSmithKline and was first approved...
- stage II or III rectal adenocarcinoma were administered single-agent dostarlimab, an anti–PD-1 monoclonal antibody, every three w****s for six months....
- inhibitors PD-1 inhibitorsTooltip Programmed cell death protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip...
- for breast and ovarian cancer. TSR-042 TSR-022 Dostarlimab – In February 2023, the FDA approved dostarlimab-gxly (Jemperli, GlaxoSmithKline LLC) for adults...
- inhibitors PD-1 inhibitorsTooltip Programmed cell death protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip...
- inhibitors PD-1 inhibitorsTooltip Programmed cell death protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip...
- inhibitors PD-1 inhibitorsTooltip Programmed cell death protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip...
- (eptifibatide) (Europe) Jalyn (dutasteride-tamsulosin hydrochloride) Jemperli (dostarlimab) Jesduvroq (daprodustat) Lacipil (lacidipine) Lamictal (lamotrigine)...
- approved by the FDA for cancer include: Alemtuzumab Bevacizumab Cetuximab Dostarlimab Gemtuzumab ozogamicin Ipilimumab Nivolumab Ofatumumab Panitumumab Pembrolizumab...